Sonnet Biotherapeutics Holdings Stock Analysis

Sonnet Stock Analysis Notes

The book value of the company was at this time reported as 1.34. The company recorded a loss per share of 11.35. Sonnet Biotherapeutics last dividend was issued on the 2nd of April 2020. The entity had 1:8 split on the 30th of September 2024. Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. Sonnet BioTherapeutics Holdings, Inc. is based in Princeton, New Jersey. Sonnet BioTherapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people. To find out more about Sonnet Biotherapeutics Holdings contact the company at 609 375 2227 or learn more at https://www.sonnetbio.com.

Sonnet Biotherapeutics Investment Alerts

Sonnet Biotherapeutics Upcoming and Recent Events

Sonnet Largest EPS Surprises

View All Earnings Estimates

Sonnet Stock Institutional Investors

Note, although Sonnet Biotherapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Sonnet Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.85 M.

Sonnet Profitablity

Management Efficiency

Sonnet Biotherapeutics has return on total asset (ROA) of (1.3399) % which means that it has lost $1.3399 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.8535) %, meaning that it created substantial loss on money invested by shareholders. Sonnet Biotherapeutics' management efficiency ratios could be used to measure how well Sonnet Biotherapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 16th of February 2025, Return On Tangible Assets is likely to drop to -1.72. In addition to that, Return On Capital Employed is likely to grow to -0.17. At this time, Sonnet Biotherapeutics' Other Assets are very stable compared to the past year. As of the 16th of February 2025, Net Tangible Assets is likely to grow to about 9 M, while Total Assets are likely to drop about 28.3 M.

Technical Drivers

As of the 16th of February 2025, Sonnet Biotherapeutics has the Coefficient Of Variation of (806.72), variance of 50.13, and Risk Adjusted Performance of (0.08). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sonnet Biotherapeutics, as well as the relationship between them.

Sonnet Biotherapeutics Price Movement Analysis

Sonnet Biotherapeutics Insider Trading Activities

Sonnet Biotherapeutics Outstanding Bonds

Sonnet Biotherapeutics Predictive Daily Indicators

Sonnet Biotherapeutics Forecast Models

Sonnet Biotherapeutics' time-series forecasting models are one of many Sonnet Biotherapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sonnet Biotherapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Sonnet Biotherapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sonnet shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Sonnet Biotherapeutics. By using and applying Sonnet Stock analysis, traders can create a robust methodology for identifying Sonnet entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Sonnet analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Sonnet analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Sonnet Biotherapeutics Holdings stock analysis indicators help investors evaluate how Sonnet Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Sonnet Biotherapeutics shares will generate the highest return on investment. By understating and applying Sonnet Biotherapeutics stock analysis, traders can identify Sonnet Biotherapeutics position entry and exit signals to maximize returns.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonnet Biotherapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sonnet Biotherapeutics. If investors know Sonnet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sonnet Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Sonnet Biotherapeutics is measured differently than its book value, which is the value of Sonnet that is recorded on the company's balance sheet. Investors also form their own opinion of Sonnet Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sonnet Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sonnet Biotherapeutics' market value can be influenced by many factors that don't directly affect Sonnet Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Sonnet Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sonnet Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sonnet Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.